Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 06 04:00PM ET
1.39
Dollar change
-0.06
Percentage change
-4.14
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsU.S. Return% 1Y-25.95% Shs Outstand Perf Week0.72%
SponsorAmplify Investments ETF Type Tagsequity Return% 3Y-44.09% Total Holdings28 Perf Month-4.79%
Fund Family Bond Type Tagscannabis Return% 5Y- AUM106.63M Perf Quarter-17.50%
Index- Average Maturity Tags- Return% 10Y NAV% Perf Half Y-21.00%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-28.17%
Active/Passive Quant Type Tags- Flows% 1M10.21% 52W Range1.29 - 2.45 Perf YTD-14.13%
Dividend TTM0.06 (4.23%) ESG Type Tags- Flows% 3M10.40% 52W High-43.27% Beta1.09
Dividend Ex-DateJun 27, 2024 Dividend Type Sector/Theme Flows% YTD4.68% 52W Low7.75% ATR (14)0.07
Expense0.75% Structure Type Region Flows% 1Y RSI (14)39.26 Volatility4.02% 3.87%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.06 Prev Close1.45
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume161.35K Price1.39
SMA20-8.90% SMA50-12.23% SMA200-23.26% Trades Volume9,350 Change-4.14%
ETFMG U.S. Alternative Harvest ETF seeks income and long-term growth of capital. The fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the "Cannabis Business" in the United States, and in derivatives that have economic characteristics similar to such securities. It will will concentrate at least 25% of its investments in the Pharmaceuticals industry and Equity Real Estate Investment Trusts (REITs) industry groups. The fund is non-diversified.